Multi-Targeted Antiangiogenic Tyrosine Kinase Inhibitors in Advanced Non-Small Cell Lung Cancer: Meta-Analyses of 20 Randomized Controlled Trials and Subgroup Analyses

BACKGROUND: Multi-targeted antiangiogenic tyrosine kinase inhibitors (MATKIs) have been studied in many randomized controlled trials (RCTs) for treatment of advanced non-small cell lung cancer (NSCLC). We seek to summarize the most up-to-date evidences and perform a timely meta-analysis. METHODS: El...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Wenhua, Wu, Xuan, Hong, Shaodong, Zhang, Yaxiong, Kang, Shiyang, Fang, Wenfeng, Qin, Tao, Huang, Yan, Zhao, Hongyun, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199622/
https://www.ncbi.nlm.nih.gov/pubmed/25329056
http://dx.doi.org/10.1371/journal.pone.0109757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199622/
https://www.ncbi.nlm.nih.gov/pubmed/25329056
http://dx.doi.org/10.1371/journal.pone.0109757

Ejemplares similares